Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
European Journal of Hospital Pharmacy : Science and Practice|September 29, 2025
Linezolid-induced eyelid angioedema: a case reportPatricia Ortiz-Fernández, Miguel Almanchel-Rivadeneyra, Elena Urbieta-Sanz
International Journal of Clinical Pharmacy|August 20, 2014
Effectiveness of pharmacist intervention in patients with chronic kidney diseaseAurelio Cabello-Muriel, Juan José Gascón-Cánovas, Elena Urbieta-Sanz, et al.
European Journal of Hospital Pharmacy : Science and Practice|February 6, 2025
Managing refractory cytomegalovirus in an immunosuppressed patient with sarcoidosis: a case report on maribavir therapyMaria Antonia Meroño Saura, María Garcia Coronel, Lorena Rentero-Redondo, et al.
Clinical Rheumatology|January 18, 2025
Assessing early therapeutic drug monitoring of adalimumab as a predictor of treatment efficacy and immunogenicity in rheumatic diseases: "early therapeutic drug monitoring of adalimumab"Patricia Ortiz-Fernández, Carles Iniesta-Navalón, Elena Urbieta-Sanz, et al.
Gastroenterologia Y Hepatologia|October 23, 2024
Comparative evaluation of point of care assay with ELISA techniques for quantifying serum concentrations of ustekinumab in inflammatory bowel disease patientsCarles Iniesta-Navalón, Manuel Ríos-Saorín, Lorena Rentero-Redondo, et al.
Atencion Primaria|July 9, 2015
[Reliability of Primary Care computerised medication records]Celia García-Molina Sáez, Elena Urbieta Sanz, Manuel Madrigal de Torres, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|March 7, 2013
[Follow-up of analytical parameters in Internal Medicine patients to detect adverse events]Aurelio Cabello-Muriel, Elena Urbieta-Sanz, Carles Iniesta-Navalón, et al.
Revista Espanola De Enfermedades Digestivas|December 4, 2024
Impact of ustekinumab exposure on clinical outcomes during induction in inflammatory bowel diseaseCarles Iniesta-Navalón, Manuel Ríos-Saorín, Lorena Rentero-Redondo, et al.
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|October 26, 2014
[Implementation of a therapeutic reconciliation procedure at admission by the emergency department]Elena Urbieta Sanz, Abel Trujilano Ruiz, Celia García-Molina Sáez, et al.
International Journal of Clinical Pharmacy|February 2, 2020
Comparison of drug survival between infliximab and adalimumab in inflammatory bowel diseaseMayte Gil-Candel, Juan José Gascón-Cánovas, Elena Urbieta-Sanz, et al.
Pageof 2